Industry News
Pharmaceutical Industry News
States and Cities Near Tentative $26 Billion Deal in Opioids Cases
The agreement would end thousands of lawsuits against the three largest distributors and Johnson & Johnson and require them to pay billions for addiction treatment and prevention.
Albireo’s rare liver disease drug Bylvay scores back-to-back approvals in U.S., Europe
Albireo's rare liver disease drug Bylvay scores back-to-back approvals in U.S., Europe esagonowsky Tue, 07/20/2021 - 17:09
Drug Companies to Pay N.Y. More Than $1 Billion to Settle Opioid Lawsuit
Three drug distributors and Johnson & Johnson are also on the verge of a $26 billion deal to settle the thousands of nationwide lawsuits.
Alexion’s new blockbuster Ultomiris keeps gaining steam as $39B AstraZeneca deal looms
Alexion's new blockbuster Ultomiris keeps gaining steam as $39B AstraZeneca deal looms fkansteiner Tue, 07/20/2021 - 11:28
Scandal aside, Biogen’s Aduhelm sales set to reach $1B next year and $6B+ by 2025: analysts
Scandal aside, Biogen's Aduhelm sales set to reach $1B next year and $6B+ by 2025: analysts nhigginsdunn Tue, 07/20/2021 - 11:23
Johnson & Johnson and 3 distributors ready to settle opioid lawsuits for $26B: report
Johnson & Johnson and 3 distributors ready to settle opioid lawsuits for $26B: report kdunleavy Tue, 07/20/2021 - 10:38
Sanofi nets valuable FDA voucher with approval for first oral regimen for neglected sleeping sickness
Sanofi nets valuable FDA voucher with approval for first oral regimen for neglected sleeping sickness aliu Tue, 07/20/2021 - 10:00
Pfizer yanks 12 Chantix lots on carcinogen concerns after pausing global shipments last month
Pfizer yanks 12 Chantix lots on carcinogen concerns after pausing global shipments last month fkansteiner Tue, 07/20/2021 - 09:18
Stevanato IPO raises $672M to fund biologics, vaccine delivery
Stevanato IPO raises $672M to fund biologics, vaccine delivery ntaylor Tue, 07/20/2021 - 08:21
Junshi commits $31M to pact with mRNA delivery specialist
Junshi commits $31M to pact with mRNA delivery specialist ntaylor Tue, 07/20/2021 - 08:15
How an Unproven Alzheimer’s Drug Got Approved
Though some of its own senior officials said there was little evidence of benefit for patients, the F.D.A. nonetheless greenlighted Biogen’s Aduhelm, or aducanumab.
With pandemic restrictions lifted, FDA restarts U.S. inspections and seeks to whittle its massive backlog
With pandemic restrictions lifted, FDA restarts U.S. inspections and seeks to whittle its massive backlog kdunleavy Mon, 07/19/2021 - 16:13
Curia CEO seized ‘huge open door’ to biologics with back-to-back buyouts of LakePharma, Integrity Bio
Curia CEO seized 'huge open door' to biologics with back-to-back buyouts of LakePharma, Integrity Bio fkansteiner Mon, 07/19/2021 - 15:26
Johnson & Johnson weighs talc bankruptcy as billions in legal costs pile up: report
Johnson & Johnson weighs talc bankruptcy as billions in legal costs pile up: report kdunleavy Mon, 07/19/2021 - 11:50
High-profile Biogen ads hype early Alzheimer’s detection as hospitals reject Aduhelm prescriptions
High-profile Biogen ads hype early Alzheimer's detection as hospitals reject Aduhelm prescriptions nhigginsdunn Mon, 07/19/2021 - 11:24
Don’t forget to nominate 2021’s fiercest women in life sciences
Don't forget to nominate 2021's fiercest women in life sciences aalidrus Mon, 07/19/2021 - 11:23
BioNTech makes a splash in cell therapy with purchase of factory, R&D platform from Gilead’s Kite
BioNTech makes a splash in cell therapy with purchase of factory, R&D platform from Gilead's Kite fkansteiner Mon, 07/19/2021 - 11:07
Kadmon eyes $15.5K pricetag and August debut for new transplant rejection med Rezurock
Kadmon eyes $15.5K pricetag and August debut for new transplant rejection med Rezurock fkansteiner Mon, 07/19/2021 - 09:40
Merck’s next-gen pneumococcal shot scores FDA nod, setting up high-stakes clash with rival Pfizer
Merck's next-gen pneumococcal shot scores FDA nod, setting up high-stakes clash with rival Pfizer kdunleavy Mon, 07/19/2021 - 09:21
In a first, Micron starts testing microneedle vaccine in kids
In a first, Micron starts testing microneedle vaccine in kids ntaylor Mon, 07/19/2021 - 06:30